Mon Mar, 26 2007
Spleen Shares Roundup
"A spleen is a terrible thing to waste."(Ann & Bill, in unison)
Spleenco Vice-President for Biocommerce Operations Splice Ripman lauded the concordant views of these two eminent market bulls, and renewed his company's dedication to bringing the highest possible level of service to the small ductless gland sector in the face of naysayers & pessimists.
"The phenomenal demand for cutting right to the spleen of the matter that we've seen in the past two decades calls for unparalleled action where the action is, and let me tell you: our investors know where the action is. We're proud to lead the way, and you should buy Spleenco today!"




